I
Irene Rota
Researcher at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Publications - 15
Citations - 445
Irene Rota is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 10 publications receiving 205 citations. Previous affiliations of Irene Rota include University of Milan.
Papers
More filters
Journal ArticleDOI
Characterization of Myocardial Injury in Patients With COVID-19.
Gennaro Giustino,Lori B. Croft,Giulio G. Stefanini,Renato Bragato,Jeffrey J. Silbiger,Marco Vicenzi,Tatyana Danilov,Nina Kukar,Nada Shaban,Annapoorna Kini,Anton Camaj,Solomon Bienstock,Eman Rashed,Karishma Rahman,Connor P. Oates,Samantha Buckley,Lindsay Elbaum,Derya Arkonac,Ryan Fiter,Ranbir Singh,Emily Li,Victor Razuk,Sam E. Robinson,Michael L. Miller,Benjamin Bier,Valeria Donghi,Marco Pisaniello,Riccardo Mantovani,Giuseppe Pinto,Irene Rota,Sara Baggio,Mauro Chiarito,Fabio Fazzari,Ignazio Cusmano,Mirko Curzi,Richard Ro,Waqas Malick,Mazullah Kamran,Roopa Kohli-Seth,Adel Bassily-Marcus,Eric Neibart,Gregory Serrao,Gila Perk,Donna M. Mancini,Vivek Y. Reddy,Sean Pinney,George Dangas,Francesco Blasi,Samin K. Sharma,Roxana Mehran,Gianluigi Condorelli,Gregg W. Stone,Valentin Fuster,Stamatios Lerakis,Martin E. Goldman +54 more
TL;DR: An international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their index hospitalization found cardiac structural abnormalities were present in nearly two-thirds of patients with myocardial injury.
Journal ArticleDOI
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients.
Marco Vicenzi,Roberta Di Cosola,Massimiliano Ruscica,Angelo Ratti,Irene Rota,Federica Rota,Valentina Bollati,Stefano Aliberti,Stefano Aliberti,Francesco Blasi,Francesco Blasi +10 more
TL;DR: In COVID-19 patients respiratory failure is associated with increased systemic blood pressure, conceivably due to the modulation of the renin-angiotensin-aldosterone system by SARS-CoV-2 infection.
Journal ArticleDOI
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.
Massimiliano Ruscica,Chiara Macchi,Simona Iodice,Gregorio Tersalvi,Irene Rota,Simone Ghidini,Leonardo Terranova,Luca Valenti,Luca Valenti,Francesco Amati,Stefano Aliberti,Stefano Aliberti,Alberto Corsini,Francesco Blasi,Francesco Blasi,Stefano Carugo,Stefano Carugo,Valentina Bollati,Marco Vicenzi,Marco Vicenzi +19 more
TL;DR: In this paper, the authors used multivariate Cox regression analysis to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality in COVID-19 patients.
Journal ArticleDOI
Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
Alessandro Santaniello,Rosa Casella,Marco Vicenzi,Marco Vicenzi,Irene Rota,Gaia Montanelli,Maria De Santis,Chiara Bellocchi,Federico Lombardi,Federico Lombardi,Lorenzo Beretta +10 more
TL;DR: CPET may be considered as a useful tool in the workup of SSc-related pulmonary hypertension and the sequential determination of the VE/VCO2 slope in DETECT-positive subjects may reduce the number of unnecessary invasive procedures without any loss in the capability to capture PAH.
Journal ArticleDOI
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
Marco Vicenzi,Marco Vicenzi,Massimiliano Ruscica,Simona Iodice,Irene Rota,Angelo Ratti,Roberta Di Cosola,Alberto Corsini,Valentina Bollati,Stefano Aliberti,Stefano Aliberti,Francesco Blasi,Francesco Blasi +12 more
TL;DR: The novelty of this observation relies on the independent positive impact of canrenone on the all-cause mortality and clinical improvement of COVID-19 patients ranging from moderate to severe diseases.